CD4 and tuberculosis: Previous studies have evaluated the diagnostic accuracy of FujiLAM and AlereLAM point-of-care TB diagnostics, primarily focusing on PLHIV in multicentre settings.3,4,7 FujiLAM was assessed using various TB diagnostic criteria, including MRS, extended microbiological reference standard (eMRS), clinical reference standard (CRS), and HIV severity, as determined by the CD4 cell count.